Ozempic maker Novo Nordisk reportedly eyes the hair-loss market
CEO Mike Doustdar sees an opportunity “to win” by building on Novo Nordisk’s experience selling drugs directly to consumers, Bloomberg reports.
TLDR
Novo Nordisk is eyeing the hair-loss market as it seeks to expand its direct-to-consumer pharmaceuticals business, Bloomberg reports. CEO Mike Doustdar described building on the Ozempic maker’s expertise in selling drugs directly to consumers as an opportunity “to win.”
Combined views
87K
1 Source, first seen 8d ago
246 likes14 comments64 saves24 reposts
